These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The role of insulin resistance in diagnosis of metabolic syndrome]. Roĭtberg GE; Ushakova TI; Dorosh ZhV Kardiologiia; 2004; 44(3):94-101. PubMed ID: 15489851 [TBL] [Abstract][Full Text] [Related]
3. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Chan JC; Tong PC; Critchley JA Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595 [TBL] [Abstract][Full Text] [Related]
4. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Lewis GF; Carpentier A; Adeli K; Giacca A Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743 [TBL] [Abstract][Full Text] [Related]
6. [Metabolic Syndrome: clinical and pathophysiological basis for a rational therapeutical approach]. Martínez R G; Alonso K R; Novik A V Rev Med Chil; 2009 May; 137(5):685-94. PubMed ID: 19701560 [TBL] [Abstract][Full Text] [Related]
7. A whole-grain cereal-based diet lowers postprandial plasma insulin and triglyceride levels in individuals with metabolic syndrome. Giacco R; Costabile G; Della Pepa G; Anniballi G; Griffo E; Mangione A; Cipriano P; Viscovo D; Clemente G; Landberg R; Pacini G; Rivellese AA; Riccardi G Nutr Metab Cardiovasc Dis; 2014 Aug; 24(8):837-44. PubMed ID: 24598599 [TBL] [Abstract][Full Text] [Related]
8. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren. Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095 [TBL] [Abstract][Full Text] [Related]
9. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome]. Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167 [TBL] [Abstract][Full Text] [Related]
10. Overweight--some facts, foibles and fallacies. Gubner RS S Afr Med J; 1973 May; 47(20):868-76. PubMed ID: 4709452 [No Abstract] [Full Text] [Related]
11. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Yki-Järvinen H Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912 [TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. den Boer M; Voshol PJ; Kuipers F; Havekes LM; Romijn JA Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):644-9. PubMed ID: 14715643 [TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview. Amihăesei IC; Chelaru L Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945 [TBL] [Abstract][Full Text] [Related]
14. [Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome]. Idzior-Waluś B Przegl Lek; 2001; 58(10):924-7. PubMed ID: 11957820 [TBL] [Abstract][Full Text] [Related]
15. Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests. Dekker MJ; Wright AJ; Mazurak VC; Marangoni AG; Rush JW; Graham TE; Robinson LE J Nutr Biochem; 2009 Sep; 20(9):694-704. PubMed ID: 18829281 [TBL] [Abstract][Full Text] [Related]
16. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults. Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534 [TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome and its cardiovascular manifestations. Sánchez-Torres RJ; Delgado-Osorio H Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068 [TBL] [Abstract][Full Text] [Related]